Revenue: As of FY2026 Q2, the actual value is USD 147.84 M, beating the estimate of USD 142.87 M.

EPS: As of FY2026 Q2, the actual value is USD 0.08, missing the estimate of USD 0.1.

EBIT: As of FY2026 Q2, the actual value is USD 2.192 M.

Second Quarter 2026 Financial Highlights

Net Sales

Superior Group of Companies, Inc. reported total net sales of $147.8 million for the second quarter ended June 30, 2026, an increase from $144.0 million in the prior year’s second quarter. Net sales for the three months ended June 30, 2026, totaled $147,836 thousand, up from $144,045 thousand in the same period of 2025.

• Segment Net Sales (Three Months Ended June 30, 2026 vs. 2025):
  • Branded Products: $98,390 thousand (2026) vs. $92,647 thousand (2025).
  • Healthcare Apparel: $27,231 thousand (2026) vs. $28,253 thousand (2025).
  • Contact Centers: $23,094 thousand (2026) vs. $23,977 thousand (2025).

Net Income

Net income for the three months ended June 30, 2026, was $1,221 thousand, compared to $1,551 thousand for the same period in 2025. This included a non-cash tradename impairment charge of $2.6 million ($2.0 million after tax). On an adjusted basis, excluding the tradename impairment charge, net income was $3,181 thousand for the second quarter of 2026, up from $1,551 thousand in the second quarter of 2025.

Gross Margin

Total gross margin for the three months ended June 30, 2026, was $56,119 thousand, an increase from $55,326 thousand in the prior year.

• Segment Gross Margin (Three Months Ended June 30, 2026 vs. 2025):
  • Branded Products: $35,872 thousand (2026) vs. $33,016 thousand (2025).
  • Healthcare Apparel: $8,967 thousand (2026) vs. $10,016 thousand (2025).
  • Contact Centers: $11,750 thousand (2026) vs. $12,613 thousand (2025).

Operating Costs and Expenses

• Cost of goods sold: $91,717 thousand for Q2 2026, up from $88,719 thousand for Q2 2025.
• Selling and administrative expenses: $51,327 thousand for Q2 2026, down from $52,240 thousand for Q2 2025.
• Interest expense, net: $981 thousand for Q2 2026, down from $1,250 thousand for Q2 2025.
• Tradename impairment charge: $2,600 thousand for Q2 2026, compared to $0 in Q2 2025, recorded in the Healthcare Apparel segment.

Adjusted EBITDA

Adjusted EBITDA was $7,676 thousand for the second quarter of 2026, up from $6,064 thousand in the second quarter of 2025. The Adjusted EBITDA margin was 5.2% in Q2 2026, compared to 4.2% in Q2 2025.

• Segment Adjusted EBITDA (Three Months Ended June 30, 2026 vs. 2025):
  • Branded Products: $11,215 thousand (2026) vs. $8,979 thousand (2025).
  • Healthcare Apparel: -$160 thousand (2026) vs. $792 thousand (2025).
  • Contact Centers: $2,045 thousand (2026) vs. $1,640 thousand (2025).

Quarterly Dividend

The Board of Directors approved a quarterly dividend of $0.14 per share, payable on August 28, 2026.

Six Months Ended June 30, 2026 Financial Highlights

For the six months ended June 30, 2026, net sales were $288,714 thousand, an increase from $281,142 thousand in the prior year period. Net income was $2,055 thousand, up from $793 thousand in the prior year. Adjusted EBITDA increased to $12,500 thousand from $9,607 thousand in the prior year.

Cash Flow from Operating Activities

Net cash provided by operating activities for the six months ended June 30, 2026, was $17,735 thousand, significantly higher than $2,946 thousand for the same period in 2025.

Cash and Cash Equivalents

Cash and cash equivalents balance at June 30, 2026, was $22,787 thousand, compared to $23,691 thousand at December 31, 2025.

2026 Full-Year Outlook

Superior Group of Companies, Inc. confirmed its full-year outlook. The Company forecasts full-year 2026 net sales in the range of $572.0 million to $585.0 million, an increase from $566.2 million in 2025. Full-year adjusted earnings per diluted share are expected to be in the range of $0.54 to $0.66, up from $0.46 in 2025.